28th January 2022 | Pharma Updates

UAE-based company willing to invest in Indian pharma firms

Apart from Indian pharmaceutical market, Niner Pharma is also planning to get into the European market.

Covaxin, Covishield get conditional approval

DCGI approval is an upgrade from the Emergency Use Authorisation (EUA) and represents a regulatory endorsement of the safe Covid vaccine shots.

Budgetary support could impel our effort for pharmaceutical innovation

There is a much requirement for incentives to propel research and development in the Indian pharma industry.

Sanjay Nayar Resigns from JB Chemicals

He steps down as a director of JB Chemicals and Pharmaceuticals.

Sun Pharma's subsidiary launches new drug for eye treatment

Sun Pharmaceutical Industries introduces CEQUA in the Canadian market, which increases ocular tissue penetration.

FDA warns Aurobindo Pharma

According to American regulator, Aurobindo Pharma has violated good manufacturing practices at a facility in Telangana.

Glenmark receives approval for BP drugs

US FDA approved Bisoprolol Fumarate and Hydrochlorothiazide for the treatment of BP patients.